Product NDC: | 43063-207 |
Proprietary Name: | R-Tanna |
Non Proprietary Name: | Phenylephrine Tannate and Chlorpheniramine Tannate |
Active Ingredient(s): | 9; 25 mg/1; mg/1 & nbsp; Phenylephrine Tannate and Chlorpheniramine Tannate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-207 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20051019 |
Package NDC: | 43063-207-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (43063-207-30) |
NDC Code | 43063-207-30 |
Proprietary Name | R-Tanna |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (43063-207-30) |
Product NDC | 43063-207 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenylephrine Tannate and Chlorpheniramine Tannate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20051019 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | CHLORPHENIRAMINE TANNATE; PHENYLEPHRINE TANNATE |
Strength Number | 9; 25 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |